Evelo Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Evelo Biosciences

29/04/2021 18:57

* Evelo Biosciences Inc  EVLO.OQ  reported a quarterly adjusted
loss of 55 cents​​ per share for the quarter ended in March. The
mean expectation of six analysts for the quarter was for a loss
of 51 cents per share.
* Revenue was $0.00​​;  analysts expected $0.00.
* Evelo Biosciences Inc's reported EPS for the quarter was a
loss of 55 cents​.
* The mean earnings estimate of analysts had fallen by
about 7.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Evelo Biosciences Inc shares had risen by 13.0% this
quarter and held steady so far this year.
* The company reported a quarterly loss of $28.2 million.
* Wall Street's median 12-month price target for Evelo
Biosciences Inc is $18.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated April 29 at 05:57 p.m. GMT.
​All figures in US Dollars.​